Dashboard Market News Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Astrana Health Inc
NASDAQ:ASTH

Watchlist Manager
Astrana Health Inc Logo
Astrana Health Inc
NASDAQ:ASTH
Watchlist
Price: 38.03 USD -0.08% Market Closed
Market Cap: $1.9B
Write Note Create Alert Ask AI

Wall St Price Targets

ASTH Price Targets Summary
Astrana Health Inc

Wall Street analysts forecast ASTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASTH is 51 USD with a low forecast of 41.41 USD and a high forecast of 68.25 USD.

ASTH Lowest Forecast
Wall Street Target
$41.41
9% Upside
ASTH Average Forecast
Wall Street Target
$51
34% Upside
ASTH Highest Forecast
Wall Street Target
$68.25
79% Upside
Lowest Forecast
Price Target
41.41 USD
9% Upside
Average Forecast
Price Target
51 USD
34% Upside
Highest Forecast
Price Target
68.25 USD
79% Upside
Astrana Health Inc Competitors:
Price Targets

Revenue
Forecast

42% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
42% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 6 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

18% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
18% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 20%.

What are analyst estimates?

Operating Income
Forecast

0% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
0% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 6 years is 25%.

What are analyst estimates?

Pre-Tax Income
Forecast

-16% / Year
Past Growth
75% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
-16% / Year
Past Growth
75% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 75%.

What are analyst estimates?

Net Income
Forecast

-24% / Year
Past Growth
82% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-24% / Year
Past Growth
82% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 82%.

What are analyst estimates?

Continue ASTH Research

Summary
ASTH intrinsic value, competitors valuation, and company profile.
DCF Valuation
ASTH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ASTH stock valuation using valuation multiples.
Wall St Estimates
ASTH price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ASTH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Astrana Health Inc listings:
F • EUR
3AM
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ASTH's stock price target?
Price Target
51 USD

According to Wall Street analysts, the average 1-year price target for ASTH is 51 USD with a low forecast of 41.41 USD and a high forecast of 68.25 USD.

What is the Revenue forecast for Astrana Health Inc?
Projected CAGR
11%

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 6 years is 11%.

What is the Gross Profit forecast for Astrana Health Inc?
Projected CAGR
20%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 20%.

What is the Operating Income forecast for Astrana Health Inc?
Projected CAGR
25%

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 6 years is 25%.

What is the Pre-Tax Income forecast for Astrana Health Inc?
Projected CAGR
75%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 75%.

What is the Net Income forecast for Astrana Health Inc?
Projected CAGR
82%

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 82%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.